Daito Pharmaceutical Co (TSE:4577) EPS (Basic): 円99.41 (TTM As of Nov. 2025)


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
71 GF Score
Price 円1,224.00
GF Value 円1,276.34
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co EPS (Basic)?

Daito Pharmaceutical Co TSE:4577 -1.37% 71 EPS (Basic) is 円99.41 as of Nov. 2025. GuruFocus rates TSE:4577 with a GF Score™ of 71/100 and a GF Value™ of 円1,276.34 (Fairly Valued). The stock has 3 warning signs investors should review.

Daito Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Nov. 2025 was 円18.08. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Nov. 2025 was 円99.41.

Daito Pharmaceutical Co's EPS (Diluted) for the three months ended in Nov. 2025 was 円18.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 was 円99.41.

Daito Pharmaceutical Co's EPS without NRI for the three months ended in Nov. 2025 was 円16.43. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Nov. 2025 was 93.51.

During the past 12 months, Daito Pharmaceutical Co's average EPS without NRIGrowth Rate was 9.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -28.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -15.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was -0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Daito Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 23.10% per year. The lowest was -28.00% per year. And the median was 8.60% per year.

Daito Pharmaceutical Co  (TSE:4577) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Daito Pharmaceutical Co EPS (Basic) Related Terms

Daito Pharmaceutical Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co EPS (Basic) Chart

Daito Pharmaceutical Co Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.37 152.46 113.82 105.00 62.74

Daito Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.17 22.88 23.24 18.08 35.21
TSE:4577
71GF Score
Daito Pharmaceutical Co Ltd TSE:4577
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Daito Pharmaceutical Co's Basic EPS for the fiscal year that ended in May. 2025 is calculated as

Basic EPS (A: May. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1908-0)/30.411
=62.74

Daito Pharmaceutical Co's Basic EPS for the quarter that ended in Nov. 2025 is calculated as

Basic EPS (Q: Nov. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(537-0)/29.840
=18.00

EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円99.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円99.41 mean?
Daito Pharmaceutical Co (TSE:4577) has a EPS (Basic) of 円99.41 as of Nov. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's EPS (Basic) too high?
Daito Pharmaceutical Co's current EPS (Basic) is 円99.41. Overall, Daito Pharmaceutical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's EPS (Basic) compare to ZTS?
Daito Pharmaceutical Co's EPS (Basic) of 円99.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current EPS (Basic) is 円99.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,276.34, compared to a current price of 円1,224.00 — trading 4.1% below its estimated fair value. The current EPS (Basic) is 円99.41. Daito Pharmaceutical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current EPS (Basic) is 円99.41 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,224.00 is trading 4.1% below its estimated GF Value™ of 円1,276.34. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • EPS (Basic): 円99.41
  • GF Value™: 円1,276.34 vs. price of 円1,224.00 (4.1% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
71GF Score

Get the complete analysis for TSE:4577

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,224.00
Price
円1,276.34
GF Value